The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 29, 2015

Filed:

Dec. 08, 2014
Applicant:

Supernus Pharmaceuticals, Inc., Rockville, MD (US);

Inventors:

Rong-Kun Chang, Rockville, MD (US);

Richard A. Couch, Chevy Chase, MD (US);

Beth A. Burnside, Bethesda, MD (US);

Assignee:

Supernus Pharmaceuticals, Inc., Rockville, MD (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 9/14 (2006.01); A61K 9/20 (2006.01); A61K 9/28 (2006.01); A61K 9/50 (2006.01); A61K 9/70 (2006.01); A61K 31/00 (2006.01); A61K 31/137 (2006.01); A61K 31/485 (2006.01); A61K 31/5513 (2006.01); A61K 47/18 (2006.01); A61K 47/22 (2006.01); A61K 47/26 (2006.01); A61K 47/34 (2006.01); A61K 47/38 (2006.01);
U.S. Cl.
CPC ...
A61K 9/2886 (2013.01); A61K 9/14 (2013.01); A61K 9/2013 (2013.01); A61K 9/2018 (2013.01); A61K 9/2853 (2013.01); A61K 9/5078 (2013.01); A61K 9/7061 (2013.01); A61K 9/7069 (2013.01); A61K 31/00 (2013.01); A61K 31/137 (2013.01); A61K 31/485 (2013.01); A61K 31/5513 (2013.01); A61K 47/186 (2013.01); A61K 47/22 (2013.01); A61K 47/26 (2013.01); A61K 47/34 (2013.01); A61K 47/38 (2013.01); A61K 9/205 (2013.01); A61K 9/2846 (2013.01); A61K 9/5084 (2013.01);
Abstract

Drug formulations having reduced abuse potential which contain one or more of (1) a bittering agent, (2) a bright deterrent/indicator dye and (3) fine insoluble particulate matter. The bittering agent and dye are in a form which does not affect proper administration of the drug, but the bittering agent creates a bitter side effect when the dosage form is crushed or chemically extracted and nasally, orally, buccally or sublingually administered and the dye produces a bright color when crushed and contacted. The fine insoluble particulate matter hinders extraction of the drug from the dosage form and, when crushed, can deter intravenous injection because of the presence of the insoluble particles or hinder injection by blocking an intravenous needle. The bright color of the dye, when extracted, also has a psychologically deterrent effect on intravenous abusers.


Find Patent Forward Citations

Loading…